Nonalcoholic Fatty Liver Disease: Evidence-Based Management and Early Recognition of Nonalcoholic Steatohepatitis
Authors:
- Nicole KellyNKNicole Kelly
- Julia WattacherilJWJulia Wattacheril
- 1 October 2019
- journal article
- research article
- Published by Elsevier in The Journal for Nurse Practitioners
- Vol. 15 (9) , 622-626
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemicHepatology Communications, 2017
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseJournal of Hepatology, 2016
- The Natural Course of Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences, 2016
- Lean NAFLD: an Underrecognized OutlierCurrent Hepatology Reports, 2016
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic SteatohepatitisGastroenterology, 2015
- Current efforts and trends in the treatment of NASHJournal of Hepatology, 2015
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severityAnnals of Medicine, 2010
- Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individualsArquivos de Gastroenterologia, 2010
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010